Bluelinea SA - Asset Resilience Ratio

Latest as of June 2025: 1.07%

Bluelinea SA (ALBLU) has an Asset Resilience Ratio of 1.07% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Bluelinea SA for a breakdown of total debt and financial obligations.

Liquid Assets

€101.56K

≈ $118.73K USD Cash + Short-term Investments

Total Assets

€9.50 Million

≈ $11.10 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how Bluelinea SA's Asset Resilience Ratio has changed over time. See what is Bluelinea SA's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Bluelinea SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Bluelinea SA (ALBLU) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€50.78K	0.53%
Short-term Investments	€50.78K	0.53%
Total Liquid Assets	€101.56K	1.07%

Asset Resilience Insights

Limited Liquidity: Bluelinea SA maintains only 1.07% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Bluelinea SA Industry Peers by Asset Resilience Ratio

Compare Bluelinea SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Vitrolife AB ST:VITR	Medical Devices	7.27%
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	Medical Devices	19.31%
Tellgen Corp SHE:300642	Medical Devices	8.60%
Lumos Diagnostics Holdings Ltd AU:LDX	Medical Devices	9.40%
T&R Biofab Co. Ltd KQ:246710	Medical Devices	0.12%
Ok Biotech Co Ltd TW:4155	Medical Devices	0.32%
Promimic AB ST:PRO	Medical Devices	8.62%
Memphasys Ltd AU:MEM	Medical Devices	0.00%

Annual Asset Resilience Ratio for Bluelinea SA (2012–2024)

The table below shows the annual Asset Resilience Ratio data for Bluelinea SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	1.97%	€184.78K ≈ $216.03K	€9.38 Million ≈ $10.97 Million	-0.28pp
2023-12-31	2.24%	€243.38K ≈ $284.54K	€10.84 Million ≈ $12.67 Million	+0.98pp
2022-12-31	1.27%	€167.04K ≈ $195.28K	€13.16 Million ≈ $15.39 Million	-3.78pp
2021-12-31	5.05%	€407.64K ≈ $476.57K	€8.07 Million ≈ $9.44 Million	+0.54pp
2020-12-31	4.51%	€335.77K ≈ $392.55K	€7.44 Million ≈ $8.70 Million	+0.42pp
2019-12-31	4.09%	€283.59K ≈ $331.55K	€6.94 Million ≈ $8.11 Million	-1.09pp
2018-12-31	5.17%	€459.00K ≈ $536.61K	€8.87 Million ≈ $10.37 Million	-13.69pp
2014-12-31	18.86%	€1.06 Million ≈ $1.24 Million	€5.61 Million ≈ $6.56 Million	+9.18pp
2013-12-31	9.68%	€324.23K ≈ $379.06K	€3.35 Million ≈ $3.91 Million	-7.52pp
2012-12-31	17.20%	€603.10K ≈ $705.08K	€3.51 Million ≈ $4.10 Million	--

pp = percentage points

About Bluelinea SA

PA:ALBLU France Medical Devices

Market Cap

$10.07 Million

€8.61 Million EUR

Market Cap Rank

#27078 Global

#471 in France

Share Price

€0.47

Change (1 day)

+2.17%

52-Week Range

€0.44 - €0.73

All Time High

€6.30